Revolutionizing diabetes care: tPBM therapy proves effective in restoring microglial health

Transcranial photobiomodulation (tPBM) treatment affected insulin therapy on microglial function.

Upper GI Damage Tied to Subsequent Parkinson’s Disease

Upper GI mucosal damage was tied to a 76% higher risk of subsequent Parkinson’s disease. The retrospective study followed GI patients for nearly 15 years.

September 7, 2024

Microsoft’s Peter Lee says ChatGPT shouldn’t be used for initial diagnosis

SAN FRANCISCO — Surging interest in generative AI among medical professionals since ChatGPT’s launch is perhaps a testament to its potential — but it could

May 16, 2024

Risk Adjusted Net Present Value: What is the current valuation of Neurocrine Biosciences’s NBI-1076986

The revenue for NBI-1076986 is expected to reach an annual total of $13 mn by 2038 globally based off GlobalData’s Expiry Model. The drug’s revenue

December 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.